Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes.
about
Ligand-based targeted therapy: a novel strategy for hepatocellular carcinomaRecent advances in hepatocellular carcinoma therapy.Micromixer Based Preparation of Functionalized Liposomes and Targeting Drug Delivery.Targeting MicroRNAs in Cancer Gene Therapy.Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers.Non-Viral Based miR Delivery and Recent Developments.
P2860
Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeted delivery of chemicall ...... negatively charged liposomes.
@ast
Targeted delivery of chemicall ...... negatively charged liposomes.
@en
type
label
Targeted delivery of chemicall ...... negatively charged liposomes.
@ast
Targeted delivery of chemicall ...... negatively charged liposomes.
@en
prefLabel
Targeted delivery of chemicall ...... negatively charged liposomes.
@ast
Targeted delivery of chemicall ...... negatively charged liposomes.
@en
P2093
P2860
P356
P1476
Targeted delivery of chemicall ...... negatively charged liposomes.
@en
P2093
Fangqi Peng
Guang Yang
Guangya Xiang
Taotao Zhou
Wendian Zhang
P2860
P304
P356
10.2147/IJN.S79598
P407
P50
P577
2015-07-29T00:00:00Z